BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Apr 23, 2008
 |  BC Extra  |  Financial News

Genzyme beats Street

Genzyme (NASDAQ:GENZ) reported 1Q08 non-GAAP diluted EPS of $0.95, beating by two cents the Street's estimate of $0.93 and up 22% from $0.78 in 1Q07. The company's 1Q08 revenues were $1.1 billion, up 25% from $883.2 million in 1Q07. The Street was...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >